scholarly journals Lower risk of severe hypoglycaemia with insulin glargine 300 U/ mL versus glargine 100 U/ mL in participants with type 1 diabetes: A meta‐analysis of 6‐month phase 3 clinical trials

2020 ◽  
Vol 22 (10) ◽  
pp. 1880-1885 ◽  
Author(s):  
Thomas Danne ◽  
Munehide Matsuhisa ◽  
Christian Sussebach ◽  
Harmonie Goyeau ◽  
Felipe Lauand ◽  
...  
Keyword(s):  
Clinical Trials ◽  
Type 1 Diabetes ◽  
Insulin Glargine ◽  
Lower Risk ◽  
Severe Hypoglycaemia ◽  
Meta Analysis ◽  
Phase 3

scholarly journals Hypoglycaemia risk with insulin degludec compared with insulin glargine in type 2 and type 1 diabetes: a pre‐planned meta‐analysis of phase 3 trials

2012 ◽  
Vol 15 (2) ◽  
pp. 175-184 ◽  
Author(s):  
R. E. Ratner ◽  
S. C. L. Gough ◽  
C. Mathieu ◽  
S. Del Prato ◽  
B. Bode ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Insulin Glargine ◽  
Meta Analysis ◽  
Insulin Degludec ◽  
Phase 3
Sign in / Sign up

Export Citation Format

Share Document